# Prednisolone

## Pred Forte 1% 5mL ophthalmic suspension

| TAH Drug Code      | [EPRED](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=EPRED)                                                                                                                                                                                                                                                                                                      |
|:-------------------|:----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | The treatment of steroid-responsive inflammation of the palpebral and bulbar conjunctiva, cornea, and anterior segment of the globe.                                                                                                                                                                                                                                        |
| Dosing             | Shake well before using. Instill 1-2 drops BID-QID into the conjunctival sac. During the initial 24 to 48 hours, the dosing frequency may be increased to 2 drops every hour if necessary. Care should be taken not to discontinue therapy prematurely.                                                                                                                     |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                               |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                               |
| Contraindications  | Acute untreated purulent ocular infections, in most viral diseases of the cornea and conjunctiva including epithelial herpes simplex keratitis (dendritic keratitis), vaccinia, and varicella, and also in mycobacterial infection of the eye and fungal diseases of ocular structures. Hypersensitivity to any of the ingredients of this preparation.                     |
| Adverse Effects    | Increased intraocular pressure with optic nerve damage, visual field defects. Posterior subcapsular cataract formation (heavy or protracted use), secondary ocular infection from fungi or viruses liberated from ocular tissues & perforation of the globe when there is thinning of the cornea or sclera. Systemic side effects may occur with extensive use of steroids. |
| Pregnancy          | Human (and Animal) Data Suggest Risk                                                                                                                                                                                                                                                                                                                                        |
| Lactation          | Compatible                                                                                                                                                                                                                                                                                                                                                                  |

